FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

432005001: Eltrombopag (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2008. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2746127011 Eltrombopag (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2771883019 Eltrombopag en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eltrombopag Is a Platelet-derived growth factor false Inferred relationship Existential restriction modifier
Eltrombopag Is a Pyrazole false Inferred relationship Existential restriction modifier
Eltrombopag Is a Hydrazine false Inferred relationship Existential restriction modifier
Eltrombopag Is a Substance with thrombopoietin receptor agonist mechanism of action true Inferred relationship Existential restriction modifier
Eltrombopag Has disposition Thrombopoietin receptor agonist true Inferred relationship Existential restriction modifier
Eltrombopag Is a Benzoic acid and/or benzoic acid derivative true Inferred relationship Existential restriction modifier
Eltrombopag Is a Hydrazine and/or hydrazine derivative true Inferred relationship Existential restriction modifier
Eltrombopag Is a Pyrazole and/or pyrazole derivative true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Eltrombopag olamine Is a False Eltrombopag Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag 25 milligram/1 each conventional release oral tablet Has active ingredient False Eltrombopag Inferred relationship Existential restriction modifier
Product containing eltrombopag Has active ingredient True Eltrombopag Inferred relationship Existential restriction modifier 1
Product containing precisely eltrombopag 50 milligram/1 each conventional release oral tablet Has active ingredient False Eltrombopag Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag 75 milligram/1 each conventional release oral tablet Has active ingredient False Eltrombopag Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag 50 milligram/1 each conventional release oral tablet Has active ingredient False Eltrombopag Inferred relationship Existential restriction modifier 1
Product containing precisely eltrombopag 50 milligram/1 each conventional release oral tablet Has basis of strength substance False Eltrombopag Inferred relationship Existential restriction modifier 1
Product containing precisely eltrombopag 25 milligram/1 each conventional release oral tablet Has active ingredient False Eltrombopag Inferred relationship Existential restriction modifier 1
Product containing precisely eltrombopag 25 milligram/1 each conventional release oral tablet Has basis of strength substance False Eltrombopag Inferred relationship Existential restriction modifier 1
Product containing precisely eltrombopag 75 milligram/1 each conventional release oral tablet Has active ingredient False Eltrombopag Inferred relationship Existential restriction modifier 1
Product containing precisely eltrombopag 75 milligram/1 each conventional release oral tablet Has basis of strength substance False Eltrombopag Inferred relationship Existential restriction modifier 1
Product containing precisely eltrombopag 50 milligram/1 each conventional release oral tablet Has precise active ingredient False Eltrombopag Inferred relationship Existential restriction modifier 1
Product containing precisely eltrombopag 25 milligram/1 each conventional release oral tablet Has precise active ingredient False Eltrombopag Inferred relationship Existential restriction modifier 1
Product containing precisely eltrombopag 75 milligram/1 each conventional release oral tablet Has precise active ingredient False Eltrombopag Inferred relationship Existential restriction modifier 1
Product containing eltrombopag in oral dose form (medicinal product form) Has active ingredient True Eltrombopag Inferred relationship Existential restriction modifier 1
Eltrombopag Has active ingredient True Eltrombopag Inferred relationship Existential restriction modifier 1
Product containing only eltrombopag in oral dose form (medicinal product form) Has active ingredient True Eltrombopag Inferred relationship Existential restriction modifier 1
Product containing precisely eltrombopag (as eltrombopag olamine) 25 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier 1
Product containing precisely eltrombopag (as eltrombopag olamine) 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier 1
Product containing precisely eltrombopag (as eltrombopag olamine) 50 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier 1
Product containing precisely eltrombopag (as eltrombopag olamine) 75 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier 1
Eltrombopag olamine Is modification of True Eltrombopag Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag (as eltrombopag olamine) 50 milligram/1 each conventional release oral tablet (clinical drug) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag (as eltrombopag olamine) 25 milligram/1 each conventional release oral tablet (clinical drug) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag (as eltrombopag olamine) 75 milligram/1 each conventional release oral tablet (clinical drug) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag 75 milligram/1 each conventional release oral tablet Has active ingredient False Eltrombopag Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag 25 milligram/1 each conventional release oral tablet Has active ingredient False Eltrombopag Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag 50 milligram/1 each conventional release oral tablet Has active ingredient False Eltrombopag Inferred relationship Existential restriction modifier
Eltrombopag 25mg oral powder sachets sugar free Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Revolade 25mg oral powder sachets (Novartis Pharmaceuticals UK Ltd) 30 sachet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Eltrombopag 25mg oral powder sachets sugar free 30 sachet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Revolade 25mg oral powder sachets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Revolade 50mg tablets (GlaxoSmithKline UK Ltd) Has active ingredient False Eltrombopag Inferred relationship Existential restriction modifier
Revolade 25mg tablets (GlaxoSmithKline UK Ltd) Has active ingredient False Eltrombopag Inferred relationship Existential restriction modifier
Eltrombopag 50mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Revolade 50mg tablets (GlaxoSmithKline UK Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Revolade 50mg tablets (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag 50 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Eltrombopag Inferred relationship Existential restriction modifier
Eltrombopag 25mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Revolade 25mg tablets (GlaxoSmithKline UK Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Revolade 25mg tablets (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag 25 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Eltrombopag Inferred relationship Existential restriction modifier
Eltrombopag 12.5mg tablets Has active ingredient False Eltrombopag Inferred relationship Existential restriction modifier
Eltrombopag 12.5mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Promacta 12.5mg tablets (Imported (United States)) Has active ingredient True Eltrombopag Inferred relationship Existential restriction modifier
Promacta 12.5mg tablets (Imported (United States)) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Promacta 75mg tablets (Imported (United States)) Has active ingredient False Eltrombopag Inferred relationship Existential restriction modifier
Eltrombopag 12.5mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Promacta 12.5mg tablets (Imported (United States)) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Revolade 75mg tablets (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Eltrombopag Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag 75 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Eltrombopag Inferred relationship Existential restriction modifier
Eltrombopag 75mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Revolade 75mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Promacta 75mg tablets (Imported (United States)) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Revolade 75mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Promacta 75mg tablets (Imported (United States)) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Eltrombopag 75mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Eltrombopag 50mg tablets 28 tablet Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Revolade 50mg tablets (GlaxoSmithKline UK Ltd) 28 tablet 4 x 7 tablets Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Revolade 50mg tablets (GlaxoSmithKline UK Ltd) Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag 50 milligram/1 each conventional release oral tablet Has basis of strength substance False Eltrombopag Inferred relationship Existential restriction modifier
Eltrombopag 25mg tablets 28 tablet Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Revolade 25mg tablets (GlaxoSmithKline UK Ltd) 28 tablet 4 x 7 tablets Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Revolade 25mg tablets (GlaxoSmithKline UK Ltd) Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag 25 milligram/1 each conventional release oral tablet Has basis of strength substance False Eltrombopag Inferred relationship Existential restriction modifier
Eltrombopag 12.5mg tablets Has basis of strength substance False Eltrombopag Inferred relationship Existential restriction modifier
Promacta 12.5mg tablets (Imported (United States)) Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Eltrombopag 12.5mg tablets 30 tablet Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Promacta 12.5mg tablets (Imported (United States)) 30 tablet Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag 75 milligram/1 each conventional release oral tablet Has basis of strength substance False Eltrombopag Inferred relationship Existential restriction modifier
Eltrombopag 75mg tablets 30 tablet Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Revolade 75mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Promacta 75mg tablets (Imported (United States)) Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Revolade 75mg tablets (Novartis Pharmaceuticals UK Ltd) Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Promacta 75mg tablets (Imported (United States)) 30 tablet Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier
Eltrombopag 75mg tablets 28 tablet Has basis of strength substance True Eltrombopag Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start